<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Ray Therapeutics raises $8M Series A+ led by Novo.</p><p>Participants in this funding round include the California Institute for Regenerative Medicine (CIRM).</p><p>Ray Therapeutics develops optogenetic gene therapies to restore vision. The company is led by CEO Paul Bresge.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>Ray Therapeutics</td></tr><tr><th>Amount</th><td>$8M</td></tr><tr><th>Lead Investor</th><td>Novo</td></tr><tr><th>Founders</th><td>Paul Bresge</td></tr><tr><th>Sectors</th><td>biopharmaceutical</td></tr></tbody></table>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Ray Therapeutics raises <strong>$8M</strong> Series A+ led by Novo.</p>
<p>Participants in this funding round include the <a href="/company/california-1/">California</a> Institute for Regenerative Medicine (CIRM).</p>
<p>Ray Therapeutics develops optogenetic gene therapies to <a href="/company/restore-1/">restore</a> vision. The company is led by CEO Paul Bresge.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Ray Therapeutics</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$8M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Novo</td>
</tr>
<tr>
<th>Founders</th>
<td>Paul Bresge</td>
</tr>
<tr>
<th>Sectors</th>
<td>biopharmaceutical</td>
</tr>
</tbody></table>
</div>


Ray Therapeutics Raises $8M From Novo

Ray Therapeutics Raises $8M From Novo | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Ray Therapeutics raises <strong>$8M</strong> Series A+ led by Novo.</p>
<p>Participants in this funding round include the <a href="/company/california-1/">California</a> Institute for Regenerative Medicine (CIRM).</p>
<p>Ray Therapeutics develops optogenetic gene therapies to <a href="/company/restore-1/">restore</a> vision. The company is led by CEO Paul Bresge.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Ray Therapeutics</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$8M</strong></td>
</tr>
<tr>
<th>Lead Investor</th>
<td>Novo</td>
</tr>
<tr>
<th>Founders</th>
<td>Paul Bresge</td>
</tr>
<tr>
<th>Sectors</th>
<td>biopharmaceutical</td>
</tr>
</tbody></table>
</div>

Ray Therapeutics Raises $8M From Novo

ABOUT THIS STORY

Mach9 Raises $34M Series A+ Led by First Round Capital

Blacksmith Raises $66M at $1B Valuation

Vectorial Raises $3M From Industry Leaders

Company	Ray Therapeutics
Amount	$8M
Lead Investor	Novo
Founders	Paul Bresge
Sectors	biopharmaceutical

Ray Therapeutics Raises $8M From Novo

ABOUT THIS STORY

More articles

Mach9 Raises $34M Series A+ Led by First Round Capital

Blacksmith Raises $66M at $1B Valuation

Vectorial Raises $3M From Industry Leaders